By Sabela Ojea
BioVie on Friday said it’s planning a public offering of common stock and warrants. Shares of the biotechnology company dropped 21% to $1.50 in after-hours trading.
Aadi Bioscience said it has received data that further supports Fyarro for the treatment of malignant PEComa. Shares of the biotechnology company climbed 24% to $2.38 in after-hours trading.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
Read the full article here
